CZA
Invesco Zacks Mid-Cap ETF
Claymore/Zacks Mid-Cap Core ETF seeks investment results that correspond to the performance of the Zacks Mid-Cap Core Index.
US
EQUITY
Passive
MANAGEMENT STYLE
185.7 M
ASSETS UNDER MGMT
72 bp
EXPENSES
Fund Basics
| Fund sponsor | Guggenheim |
| Category | US |
| Asset class | Equity |
| Website | link... |
| Inception date | Apr 02, 2007 |
| Assets (mns) | $186 |
| Expense ratio | 72 bp |
| Currency | USD |
Sector Breakdown
Fund Structure
| Regulation | Open-Ended Fund |
| Distributions | Annually |
| Taxation | 1099 |
| Stock selection | Proprietary |
| Weighting | Market Cap |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| AGILENT TECHNOLOGIES INC | 2.2 % |
| HARTFORD FINANCIAL SVCS GRP | 2.0 % |
| IQVIA HOLDINGS INC | 2.0 % |
| PRUDENTIAL FINANCIAL INC | 1.9 % |
| XYLEM INC | 1.9 % |
| GE HEALTHCARE TECHNOLOGIES INC. | 1.9 % |
| OTIS WORLDWIDE CORPORATION | 1.9 % |
| LAS VEGAS SANDS CORP | 1.9 % |
| DUPONT DE NEMOURS INC | 1.8 % |
| CONSOLIDATED EDISON INC | 1.8 % |
Constituent Breakdown
| Number of holdings | 96 |
| Herfindahl-Hirschman Index | 125 |
| Wgt avg mkt cap (mns) | $22,602 |
| Large cap (>$10bn) | 88.0% |
| Mid cap ($2-10bn) | 8.6% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 94.0% |
| Emerging mkts. | 2.5% |
Country Exposure
 |
UNITED STATES | 80.0 % |
 |
BRITAIN | 4.0 % |
 |
CANADA | 3.2 % |
 |
BERMUDA | 2.5 % |
 |
IRELAND | 2.1 % |
 |
CHINA | 1.4 % |
 |
SINGAPORE | 1.2 % |
 |
ISRAEL | 1.1 % |
 |
PERU | 1.1 % |
Historical Performance
Standardized Performance (as of 11/30/2025)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 7.7% | -1.5% | 12.3% | 6.3% | 8.4% | 8.4% | -- | 8.3% |
| Dividend Yield | 0.0% | 1.2% | 1.5% | 1.6% | 1.5% | 1.5% | -- | 1.1% |
| Total Returns | 7.7% | -0.3% | 13.8% | 7.9% | 9.9% | 9.9% | -- | 9.4% | Ann. Volatility | 18.4% | 18.1% | 15.5% | 15.2% | 16.3% | 19.5% | -- | 20.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.78 | 71% |
| MSCI EAFE | 0.83 | 58% |
| MSCI Emg Mkts | 0.66 | 42% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.21% |
Technical Indicators
| 30d moving avg. (EMA) | $109.51 |
| Relative strength (RSI) | 57 |
| MACD/Signal | 0.39/0.07 |
| Bollinger Bands (Upper/Lower) | $112.21/$106.58 |
| Short interest (% of AUM) | 0.0% |
Distributions
Assets Under Management (mns)
Money Flows (mns)
Short Interest (as % of shares outstanding)
Long Money Flows (mns)
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. CZA |
Expenses vs. CZA |
ALTAR Score™ vs. CZA |
|---|---|---|---|---|
| NUMV | Nuveen ESG Mid-Cap Value ETF | 20.5% | -41 bp | +6.9% |
| AVMV | Avantis U.S. Mid Cap Value ETF | 17.6% | -52 bp | +8.8% |
| AVMC | Avantis U.S. Mid Cap Equity ETF | 16.6% | -54 bp | +6.8% |
| ONEV | State Street SPDR Russell 1000 Low Volatility Focus ETF | 16.5% | -52 bp | +8.2% |
| IQSM | IQ Candriam U.S. Mid Cap Equity ETF | 15.7% | -57 bp | +6.0% |
| MCDS | JPMorgan Fundamental Data Science Mid Core ETF | 15.6% | -37 bp | +5.7% |
| IWS | iShares Russell Mid-Cap Value ETF | 14.9% | -49 bp | +7.1% |
| VOE | Vanguard Mid-Cap Value ETF | 14.7% | -65 bp | +7.8% |
| JHMM | John Hancock Multifactor Mid Cap ETF | 14.5% | -30 bp | +6.3% |
| FLQM | Franklin U.S. Mid Cap Multifactor Index ETF | 14.3% | -42 bp | +8.2% |
Risk and Returns: CZA vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- | |
| Book value per share | -- | -- | -- | -- | -- | -- | -- | |
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2024 | 2025 | 2026 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 12/5/2025
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
OVERWEIGHT
Above average appreciation potential. A rating of OVERWEIGHT is assigned to ETFs with ALTAR Scores in the 4th quintile (ranking higher than 60%-80%) of their category. Typically, funds in this category consist of stocks trading at attractive valuations and/or having above-average fundamentals.
ALTAR Score™
CZA
7.5%
Cat. Avg
5.6%
ALTAR Score™ Calculation
Category Overview
There are 1021 funds in the US Equity category, with an average ALTAR Score™
of 5.6% and a standard deviation of
2.3%. CZA's ALTAR Score™ is approximately
0.8 standard deviations
above
the category average. This places CZA in the 79th percentile among funds in the category.
Sell Side Consensus Rating
Sell-side recommendations on the ETF's individual constituents
CZASELL
U/W
HOLD
O/W
BUY